VANCOUVER, May 17 /PRNewswire-FirstCall/ - At QLT Inc.'s annual general meeting, held today in Vancouver, B.C., shareholders elected Philip Livingston to its board of directors. Concurrent to the new addition, E. Duff Scott and Ronald D. Henriksen are retiring from the board following a combined 27 years of distinguished service.
“Phil is an ideal complement to QLT’s board of directors,” said C. Boyd Clarke, Chairman and Director of QLT Inc. “His extensive board experience, expertise in corporate governance and strong finance background will be invaluable assets as QLT progresses through the next phase of its strategic development.”
Philip B. Livingston is currently Vice Chairman of Approva Corporation (a provider of enterprise controls management software), a role that he has held since 2005. From 2003 to 2005, he had been Chief Financial Officer and a member of the board of World Wrestling Entertainment, Inc. (a media and entertainment company). Prior to that, he served as President and Chief Executive Officer of Financial Executives International, a membership organization for chief financial officers, controllers and treasurers, a position that he held from 1999 to 2003. Mr. Livingston is also on the board of directors of Cott Corporation (a publicly traded retailer-branded soft drink company). Mr. Livingston holds an MBA from the University of California, Berkeley, California, U.S.A., is a Certified Public Accountant and is on the Board of Examiners for the Uniform CPA Examination of the American Institute of Certified Public Accountants.
“On behalf of the board and management, we’d like to thank Duff and Ron for their contributions and dedication to QLT,” said C. Boyd Clarke. “We owe them a debt of gratitude for their service and leadership to the Company and we will miss the wisdom and insight that they have provided to QLT as it has matured.”
The shareholders also re-elected board members C. Boyd Clarke (Chairman), Robert Butchofsky, Bruce Carter, Peter Crossgrove, Ian Massey, Alan Mendelson, Richard Vietor and Jack Wood, and approved the appointment of Deloitte & Touche LLP as independent auditors of the Company for the ensuing year.
QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Our research and development efforts are focused on pharmaceutical products in the fields of ophthalmology and dermatology. In addition, we utilize two unique technology platforms, photodynamic therapy and Atrigel(R), to create products such as Visudyne(R) and Eligard(R). For more information, visit our web site at www.qltinc.com.
Atrigel is a registered trademark of QLT USA, Inc. Visudyne is a registered trademark of Novartis AG. Eligard is a registered trademark of Sanofi-aventis. QLT Inc. is listed on The NASDAQ Stock Market under the trading symbol “QLTI” and on The Toronto Stock Exchange under the trading symbol “QLT.”
CONTACT: QLT Inc.: Vancouver, Canada, Therese Hayes, Tamara Hicks, Telephone: (604) 707-7000 or 1-800-663-5486, Fax: (604) 707-7001
QLT Inc.
CONTACT: QLT Inc.: Vancouver, Canada, Therese Hayes, Tamara Hicks,Telephone: (604) 707-7000 or 1-800-663-5486, Fax: (604) 707-7001
